The Filing Desk

Acadia Pharmaceuticals vs Ionis Pharmaceuticals

Acadia Pharmaceuticals ACAD · Ionis Pharmaceuticals IONS · Pharmaceuticals

Acadia Pharmaceuticals reported revenue of $1.1 billion in fiscal 2025, about the same as Ionis Pharmaceuticals' $944 million in fiscal 2025. Acadia Pharmaceuticals' revenue grew 11.9% in its latest year, and Ionis Pharmaceuticals' grew 33.8%. Acadia Pharmaceuticals had an operating margin of 9.8%, against -40.5% at Ionis Pharmaceuticals. Free cash flow was $105 million at Acadia Pharmaceuticals and −$320 million at Ionis Pharmaceuticals.

Side by side

Acadia PharmaceuticalsIonis Pharmaceuticals
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$1.1B$944M
Revenue growth11.9%33.8%
Revenue growth a year, last 5 years19.4%5.3%
Gross margin91.7%98.3%
Operating margin9.8%−40.5%
Net margin36.5%−40.4%
Free cash flow$105M−$320M
Free cash flow margin9.8%−33.9%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count2.1%7.0%
Last close$17.59$27.22
P/E at the last close8.3×—
Insider trades, last 12 monthssold $2.5 millionbought $1.1 million, sold $117.5 million
Piotroski F-score—3 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Acadia PharmaceuticalsIonis Pharmaceuticals
Operating margin
Percent of revenue
Acadia PharmaceuticalsIonis Pharmaceuticals
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Acadia PharmaceuticalsIonis Pharmaceuticals

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Acadia Pharmaceuticals and Ionis Pharmaceuticals pages.